Contemporary Management of Psoriasis For the Family Medicine Physician: A Patient-Centered Approach

 


Release Date: December 21, 2017
Expiration Date: December 21, 2018
Media: Internet - based

Activity Overview

This educational activity will define the unique aspects of care that practitioners provide to patients with psoriasis, including facilitating conversations about managing disease, setting expectations, and selecting treatment options, including when treatment response or tolerability is suboptimal. The importance of relationship building also will be explored. Practical strategies to address patient barriers, including lack of knowledge about psoriasis, fear of injections, and adverse effect risks will be provided. By engaging patients in their psoriasis care plans, family physicians can optimize outcomes and manage psoriasis and its comorbidities.
 
Please note that there are several patient cases presented throughout the activity revolving around screening, diagnosis, and treatment for psoriasis and psoriatic arthritis. These cases provide a wide variety of patient scenarios that may be applicable to many different practice settings. All of the cases are available for your review in the PDF provided within the activity.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
 

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.


Target Audience

Physicians and Family Medicine Physicians

Learning Objectives

At the conclusion of this educational activity, participants will be able to:

  • Explain how to screen patients on comorbidities associated with psoriasis
  • Describe individualized treatment strategies for patients with psoriasis based on evidence-based guidelines, safety, and efficacy of pharmacologic treatment options, disease severity, and patient quality-of-life factors
  • Recognize effective methods for improving patient-provider communication and incorporating patient-specific factors to help patients with psoriasis adhere to prescribed therapy

Faculty, Staff, and Planners' Disclosures

Paul Doghramji, MD, FAAFP
Family Practice Physician
Collegeville Family Practice
Pottstown Medical Specialists, Inc.
Medical Director of Health Services
Ursinus College
Collegeville, Pennsylvania

Disclosure: Consultant: Purdue Pharma, Ironwood Pharma, Merck; Speakers Bureau: Merck; Stock/Shareholder: Pfizer

 
Arthur M. Mandelin, MD, PhD 
Assistant Professor of Medicine (Rheumatology)
Northwestern University Feinberg
School of Medicine
Chicago, Illinois

Disclosure: Grant/Research Support: Pfizer; Consultant: Cardinal Health, Crescendo, Horizon, Pfizer; Speakers Bureau: AbbVie, Genentech, Sanofi, UCB

 
Jashin J. Wu, MD, FAAD
Director of Dermatology Research
Kaiser Permanente
Los Angeles Medical Center
Los Angeles, California

Disclosure: Grant/Research Support: AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Regeneron

 
Ty Westfall
Psoriasis Patient Advocate
Allen, Texas

The staff of PER® have no relevant financial relationships with commercial interests to disclose.
 

Activity Disclaimer

Global Education Group and Physicians’ Education Resource®, LLC (PER®) (formerly ArcMesa Educators) strive to provide the highest level of service. However, unforeseen circumstances may necessitate the rescheduling or cancellation of live events, including, but not limited to, webinars, hosted by PER®. PER® reserves the right to cancel an event without notice. PER® will not be responsible for any expenditure incurred due to the cancellation.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PER® do not recommend the use of any agent outside of the labeled indications.
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

System Requirements

PC-based participants
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Macintosh®-based participants
Required: Mac OS® X 10.4.11 (Tiger®) or newer
 
For questions about this Internet CPE activity, please contact: ceinfo@permedical.com
Privacy Policy and Terms of Use Information: www.gotoper.com/terms






Become a Member

Forgot Password?
Filter By